beta-lapachone has been researched along with Cancer of Mouth in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, YJ | 1 |
| Bang, W | 1 |
| Shin, JC | 1 |
| Park, SM | 1 |
| Cho, JJ | 1 |
| Choi, YH | 1 |
| Seo, KS | 1 |
| Choi, NJ | 1 |
| Shim, JH | 1 |
| Chae, JI | 1 |
1 other study available for beta-lapachone and Cancer of Mouth
| Article | Year |
|---|---|
Downregulation of Sp1 is involved in β-lapachone-induced cell cycle arrest and apoptosis in oral squamous cell carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; D | 2015 |